Skip to main content
Enter a keyword
  • Login
  • Home

    Main navigation

    Menu
    • US Law
      • Chapter 15 Cases
    • Regions
      • Africa
      • Asia Pacific
      • Europe
      • North Africa/Middle East
      • North America
      • South America
    • Headlines
    • Education Resources
      • ABI Committee Articles
      • ABI Journal Articles
      • Covid 19
      • Conferences and Webinars
      • Newsletters
      • Publications
    • Events
    • Firm Articles
    • About Us
      • ABI International Board Committee
      • ABI International Member Committee Leadership
    • Join
    What Rescheduling Could Mean For Cannabis Bankruptcies
    2024-03-27

    More than 75% of the U.S. population lives in states that have legalized cannabis for adult and/or medical use.

    Pursuant to a 2022 directive from President Joe Biden, a 2023 recommendation of the U.S. Department of Health and Human Services, and a scientific review released in January supporting the HHS's recommendation, the U.S. Drug Enforcement Administration is now evaluating whether to reclassify cannabis as a Schedule III drug.

    Filed under:
    USA, Healthcare & Life Sciences, Insolvency & Restructuring, Product Regulation & Liability, Duane Morris LLP, Cannabis, US Department of Justice
    Authors:
    Lawrence J. Kotler , Ryan Spengler
    Location:
    USA
    Firm:
    Duane Morris LLP
    Health Care Provider Bankruptcy Update: Patient Care Ombudsman Not Necessary in Every Health Care Business Bankruptcy Case
    2023-12-07

    Recent headlines have starkly illuminated the headwinds facing health care providers struggling to recover from a host of financial pressures. Many providers have resorted to filing for bankruptcy protection as a way, among other things, to right-size their balance sheets or effect a sale of their assets or businesses.

    Filed under:
    USA, Healthcare & Life Sciences, Insolvency & Restructuring, Litigation, Jones Day, Medicare, Medicaid, SIPP, Office of Foreign Assets Control (USA), US Congress
    Authors:
    Mark A. Cody
    Location:
    USA
    Firm:
    Jones Day
    Federal Bankruptcy Court Stays Envision Healthcare Litigation in California
    2023-08-04

    From the West Coast Healthcare Desk is a new ongoing series of Holland & Knight Healthcare Blog articles and alerts focused on healthcare industry developments and points of interest in the West Coast healthcare marketplace. Holland & Knight's nationally ranked healthcare practice has been focused on healthcare compliance, transactional, reimbursement and operational trends that have often started in California before spreading nationwide – managed care and various capitated and quality-based reimbursement models being the most obvious examples.

    Filed under:
    USA, California, Healthcare & Life Sciences, Insolvency & Restructuring, Litigation, Holland & Knight LLP, Private equity
    Location:
    USA
    Firm:
    Holland & Knight LLP
    Envision’s bankruptcy provides insight into all that is ailing the Healthcare Industry
    2023-06-16

    The increase in bankruptcy filings that restructuring professionals have been expecting is now arriving. With rising inflation, increased interest rates, tightening credit markets, labor shortages and supply chain disruptions, we are starting to see a dramatic increase in filings. Last week the American Bankruptcy Institute noted that commercial Chapter 11 filings increased 105% in May 2023 as compared to May 2022 and across the board filings are on the rise as well.

    Filed under:
    USA, Healthcare & Life Sciences, Insolvency & Restructuring, Litigation, Squire Patton Boggs, Private equity, Supply chain, Coronavirus
    Authors:
    Peter R. Morrison
    Location:
    USA
    Firm:
    Squire Patton Boggs
    The State of Third-Party Releases After the Purdue Pharma Decision
    2023-06-15

    In a highly anticipated decision issued on May 30, 2023, the Second Circuit Court of Appeals rendered its opinion in Purdue Pharma LP v. City of Grand Prairie (In re Purdue Pharma LP)1 approving a Chapter 11 plan’s inclusion of a nonconsensual release of creditors’ direct claims against non-debtor third parties.

    This client alert describes the history of the case, identifies some of the key takeaways from the decision and outlines where other jurisdictions in the country stand on nonconsensual third-party releases.

    Filed under:
    USA, Healthcare & Life Sciences, Insolvency & Restructuring, Litigation, Hunton Andrews Kurth LLP, Bankruptcy, US Congress, Second Circuit
    Authors:
    Gregory G. Hesse , Kollin Bender
    Location:
    USA
    Firm:
    Hunton Andrews Kurth LLP
    Insolvenzen von Pflegeheimbetreibern - was passiert mit Oma, dem Miet-/Pachtverhältnis und dem Betrieb?
    2023-02-16

    In den letzten Wochen haben in Deutschland zwei größere Betreiber der stationären Pflege und von betreutem Wohnen Insolvenz angemeldet. Auch wenn dies aus unserer Sicht nur Einzelfälle sind und kein Krankheitssyndrom der Pflegebranche darstellt, geben diese Fälle Anlass für eine kurze rechtliche Orientierung wie sich solche Insolvenzen auf alle Leistungsbeziehungen auswirken.

    Auswirkungen auf Miet- und Pachtverhältnisse

    Filed under:
    Germany, Healthcare & Life Sciences, Insolvency & Restructuring, Real Estate, Hogan Lovells
    Authors:
    Dr. Susann Brackmann , Justus Frank
    Location:
    Germany
    Firm:
    Hogan Lovells
    UK restructuring a year in retrospect
    2023-02-01

    UK Restructuring A YEAR IN RETROSPECT 2 Contents Introduction Birmingham London North West Yorkshire UK team UK Restructuring Employment UK Restructuring Section Header Section Header Contents 3 Robert Russell UK Head of Restructuring +44 (0)161 235 4147 [email protected] 2022 – Unpredictable circumstances It would be fair to say that 2022 was not an easy year.

    Filed under:
    United Kingdom, Derivatives, Healthcare & Life Sciences, Insolvency & Restructuring, Litigation, Trade & Customs, DLA Piper, Supply chain, Fintech, International Swaps and Derivatives Association
    Location:
    United Kingdom
    Firm:
    DLA Piper
    UPDATED: Emergency legislation and measures around the world (COVID-19)
    2020-07-20

    UPDATED 3 AUGUST 2020

    Updates marked with *

    Updated: Ireland, Israel

    We take a look at some of the recent emergency legislation and measures implemented by various nations around the world in response to COVID-19. As this is a rapidly developing crisis, please ensure you keep a close eye on the Lexology Coronavirus hub page for the most up-to-date information.

    Filed under:
    Argentina, Australia, Brazil, Canada, Chile, China, Colombia, European Union, France, Germany, Global, Guernsey, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Netherlands, New Zealand, Portugal, Russia, Singapore, Slovakia, Spain, Sweden, Switzerland, Thailand, Turkey, Ukraine, United Arab Emirates, United Kingdom, USA, Company & Commercial, Employment & Labor, Healthcare & Life Sciences, Insolvency & Restructuring, Insurance, Leisure & Tourism, Public, Tax, Coronavirus, Coronavirus compliance, European Commission, HM Revenue and Customs (UK)
    Location:
    Argentina, Australia, Brazil, Canada, Chile, China, Colombia, European Union, France, Germany, Global, Guernsey, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Netherlands, New Zealand, Portugal, Russia, Singapore, Slovakia, Spain, Sweden, Switzerland, Thailand, Turkey, Ukraine, United Arab Emirates, United Kingdom, USA
    Federal Agencies Issue Request for Information on the Regulation of Biotechnology
    2022-12-23

    On December 20, 2022, the Office of Science and Technology Policy (OSTP) issued a notice of request for information (RFI) on the regulation of biotechnology on behalf of the U.S. Food and Drug Administration (FDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Department of Agriculture (USDA).

    Filed under:
    USA, Healthcare & Life Sciences, Insolvency & Restructuring, Biotechnology, US Environmental Protection Agency, US Department of Agriculture
    Location:
    USA
    Bankruptcy Court Continues to be a Battleground on Key Healthcare Provider Issues
    2022-10-10

    The Bankruptcy Protector

    Filed under:
    USA, Healthcare & Life Sciences, Insolvency & Restructuring, Litigation, Nelson Mullins Riley & Scarborough LLP, Medicare, Medicaid, Bankruptcy, Ninth Circuit
    Authors:
    Jody A. Bedenbaugh
    Location:
    USA
    Firm:
    Nelson Mullins Riley & Scarborough LLP

    Pagination

    • First page « First
    • Previous page ‹‹
    • …
    • Page 20
    • Page 21
    • Page 22
    • Page 23
    • Current page 24
    • Page 25
    • Page 26
    • Page 27
    • Page 28
    • …
    • Next page ››
    • Last page Last »
    Home

    Quick Links

    • US Law
    • Headlines
    • Firm Articles
    • Board Committee
    • Member Committee
    • Join
    • Contact Us

    Resources

    • ABI Committee Articles
    • ABI Journal Articles
    • Conferences & Webinars
    • Covid-19
    • Newsletters
    • Publications

    Regions

    • Africa
    • Asia Pacific
    • Europe
    • North Africa/Middle East
    • North America
    • South America

    © 2025 Global Insolvency, All Rights Reserved

    Joining the American Bankruptcy Institute as an international member will provide you with the following benefits at a discounted price:

    • Full access to the Global Insolvency website, containing the latest worldwide insolvency news, a variety of useful information on US Bankruptcy law including Chapter 15, thousands of articles from leading experts and conference materials.
    • The resources of the diverse community of United States bankruptcy professionals who share common business and educational goals.
    • A central resource for networking, as well as insolvency research and education (articles, newsletters, publications, ABI Journal articles, and access to recorded conference presentation and webinars).

    Join now or Try us out for 30 days